Evidence map›Paper›PMID 30816285›Full record

Trial reportJournal of human genetics2019

Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian Indian patients of ADPKD.

Shewata Pandita, Vijaya Ramachandran, Prahlad Balakrishnan, Arndt Rolfs, Oliver Brandau, Sabrina Eichler, Anil Kumar Bhalla, Dinesh Khullar, Vindu Amitabh, Sivaramakrishnan Ramanarayanan and 5 more

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Long-Read Sequencing Identified aHuman mutation · 2024
    Article
  5. Review
  6. Genetic Testing in Pediatric Kidney Disease.Indian journal of pediatrics · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Shewata PanditaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India. pandita.shwet07@gmail.com.ORCID http://orcid.org/0000-0001-9695-3209
Vijaya RamachandranInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Prahlad BalakrishnanInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.ORCID http://orcid.org/0000-0003-0740-5476
Arndt RolfsCentogene AG, Rostock, Germany.
Oliver BrandauCentogene AG, Rostock, Germany.
Sabrina EichlerCentogene AG, Rostock, Germany.
Anil Kumar BhallaInstitute of Renal Sciences, Sir Ganga Ram Hospital, New Delhi, India.
Dinesh KhullarDepartment of Nephrology & Renal Transplant Medicine, Max Super Speciality Hospital, New Delhi, India.
Vindu AmitabhDepartment of Nephrology, Safdarjung Hospital, New Delhi, India.
Sivaramakrishnan RamanarayananDepartment of Nephrology, PGIMER-Dr Ram Manohar Lohia Hospital, Delhi, India.
Vijay KherDivision of Nephrology & Renal Transplant Medicine, Fortis Escorts, New Delhi, India.
Jyotsna VermaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Sudha KohliInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Renu SaxenaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India.
Ishwar Chander VermaInstitute of Medical Genetics and Genomics, Sir Ganga Ram Hospital, New Delhi, India. icverma@gmail.com.
Sir Ganga Ram Hospital · INCentogene (Germany) · DEAtal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital · INGuru Gobind Singh Indraprastha University · INMax Super Speciality Hospital · INSafdarjang Hospital · INSt George’s University Hospitals NHS Foundation Trust · GB

Funding

Indian Council of Medical Research (ICMR) IRIS ID 2011-09610
6 · The paper itself

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD) accounts for 2.6% of the patients with chronic kidney disease in India. ADPKD is caused by pathogenic variants in either PKD1 or PKD2 gene. There is no comprehensive genetic data from Indian subcontinent. We aimed to identify the pathogenic variants in the heterogeneous Indian population. PKD1 and PKD2 variants were identified by direct gene sequencing and/or multiplex ligation-dependent probe amplification (MLPA) in 125 unrelated patients of ADPKD. The pathogenic potential of the variants was evaluated computationally and were classified according to ACMG guidelines. Overall 300 variants were observed in PKD1 and PKD2 genes, of which 141 (47%) have been reported previously as benign. The remaining 159 variants were categorized into different classes based on their pathogenicity. Pathogenic variants were observed in 105 (84%) of 125 patients, of which 99 (94.3%) were linked to PKD1 gene and 6 (6.1%) to PKD2 gene. Of 159 variants, 97 were novel variants, of which 43 (44.33%) were pathogenic, and 10 (10.31%) were of uncertain significance. Our data demonstrate the diverse genotypic makeup of single gene disorders in India as compared to the West. These data would be valuable in counseling and further identification of probable donors among the relatives of patients with ADPKD.

Indexed as

Genetic LinkageGenetic VariationAdolescentAdultAgedAged, 80 and overFemaleHumansIndiaMaleMiddle AgedPolycystic Kidney, Autosomal DominantTRPP Cation ChannelsTRPP Cation Channels

Identifiers

PMID30816285
OpenAlexW2916248874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.